Search Results
Jun 15, 2026, 02:27 ET FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit with the Schall Law Firm
FSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 02:26 ET SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm
SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 02:21 ET SES AI Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SES
SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of
More news about: DJS Law Group LLP
Jun 15, 2026, 02:12 ET Globant S.A. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GLOB
GLOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of
More news about: DJS Law Group LLP
Jun 15, 2026, 02:12 ET GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm
GLOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 02:01 ET Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
in two participants and managed with short-term hydrocortisone treatment.Part B of the ongoing Phase II study is investigating SC administration of asedebart in adults with CD.1 This next step, Part B, is designed to further evaluate direct ACTH neutralization, including effects on cortisol
More news about: H. Lundbeck A/S
Jun 15, 2026, 01:57 ET Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
in two participants and managed with short-term hydrocortisone treatment.Part B of the ongoing Phase II study is investigating SC administration of asedebart in adults with CD.1 This next step, Part B, is designed to further evaluate direct ACTH neutralization, including effects on cortisol
More news about: H. Lundbeck A/S
Jun 15, 2026, 01:30 ET SINTRONES Advances Battlefield Intelligence with Tactical Edge AI at EUROSATORY 2026
SINTRONES Technology Corp. (TPEx: 6680), a global provider of rugged embedded and Edge AI computing solutions, will exhibit at EUROSATORY 2026 (Hall 5B, Booth BC465). The company will showcase its latest Tactical Edge AI computing platforms for battlefield intelligence, autonomous military operations,
More news about: SINTRONES
Jun 14, 2026, 23:34 ET 스타트레이더, 두바이에서 KTH 동문 이브닝 개최 -- AI, 기술, 혁신 리더들을 한자리에
multimedia:https://www.prnewswire.com/kr/news-releases/uC2A4uD0C0uD2B8uB808uC774uB354u002Cu002DuB450uBC14uC774uC5D0uC11Cu002Du006Bu0074u0068u002DuB3D9uBB38u002DuC774uBE0CuB2DDu002DuAC1CuCD5Cu002D-302799919.htmlSOURCE
More news about: STARTRADER
Jun 14, 2026, 23:30 ET Osstem Implant Accelerates Innovation in India with 'Denall TV', a Digital Dental Education Hub
dental implant market through the continued provision of high-quality educational content."Moving forward, Osstem Implant plans to enhance its B2C PR strategies centered around the Denall TV platform and lead the popularization of digital dental treatment in India through close communication with
More news about: OSSTEM IMPLANT Co., Ltd.
Jun 14, 2026, 23:30 ET Osstem Implant ने 'Denall TV' नामक Digital Dental Education Hub के साथ भारत में नवाचार को गति दी
गुणात्मक दोनों तरह की वृद्धि को बढ़ावा देने के लिए प्रतिबद्ध हैं।"आगे बढ़ते हुए, Osstem Implant की योजना Denall TV प्लेटफॉर्म पर केंद्रित अपनी B2C PR रणनीतियों को बढ़ाने और स्थानीय चिकित्सकों के साथ घनिष्ठ संवाद के माध्यम से भारत में डिजिटल दंत चिकित्सा उपचार को लोकप्रिय बनाने की है।फ़ोटो
More news about: OSSTEM IMPLANT Co., Ltd.
Jun 14, 2026, 22:00 ET Haivivi BubblePal: Redefine Playtime with Screen-Free AI Plush Toy for Modern Families
https://www.amazon.com/gp/product/B0GS9ZN8D8?maas=maas_adg_6DDA14BAC41F13666C1A061E15E78A4D_afap_abs&ref_=aa_maas&tag=maasTikTok: https://vt.tiktok.com/ZTBFqpcWX/
More news about: Haivivi (Yueran Innovation)
Jun 14, 2026, 21:25 ET 【EHA2026】亞盛醫藥多項臨床數據亮相，彰顯血液腫瘤領域全球創新實力
EFFICACY OF OLVEREMBATINIB (HQP1351) COMBINED WITH LISAFTOCLAX (APG-2575) IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R PH+ ALL): RESULTS OF A PHASE 1B STUDY一項1B期臨床研究結果：奧雷巴替尼（HQP1351）聯合利沙托克拉（APG-2575）治療復發/難治性（R/R）費城染色體陽性急性淋巴細胞白血病（Ph+
More news about: 亞盛醫藥
Jun 14, 2026, 20:15 ET CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026
median Tmax of 10.5 days.Data for CT1190B in Relapsed/Refractory B-cell Non-Hodgkin's LymphomaA total of 13 patients (10 with large B-cell lymphoma [LBCL] and 3 with follicular lymphoma[FL]) received CT1190B infusion, with 1, 2, 4, and 6 patients dosed with 1.5×10⁸,
More news about: CARsgen Therapeutics
Jun 14, 2026, 20:01 ET Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
platform, accelerating the development of innovative therapies.By integrating Harbour Mice®, HBICE®, HCAb PLUS™, a single B-cell cloning platform and AI technologies, Harbour BioMed has built a highly efficient and distinctive antibody discovery engine for developing next-generation
More news about: Harbour BioMed
Jun 14, 2026, 17:45 ET Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Empyrean Anaheim Resort, Inc., for Alleged Failure to Provide Required Meal Periods and Rest Periods
According to the lawsuit filed, Empyrean Anaheim Resort, Inc. allegedly (a) failed to pay minimum wages, (b) failed to pay overtime wages, (c) failed to provide legally required
More news about: Blumenthal Nordrehaug Bhowmik De Blouw LLP
Jun 14, 2026, 17:44 ET HEC 그룹, 싱가포르 마리나 베이 샌즈에 첫 해외 플래그십 스토어 오픈
1:1 비율을 달성하기 위해 신중하게 제어된 성숙 과정을 거친다. 6건의 PCT 특허를 포함한 104건의 글로벌 특허를 보유하고 10회 이상의 엄격한 품질 검사를 거치는 각 제품은 안전성, 일관성 및 품질에 대한 회사의 헌신을 반영한다.마리나 베이 샌즈 B1-06에 위치한 HEC 라이프+ 플래그십 스토어는 브랜드의 첫 번째 해외 소매점으로, 글로벌 성장 및 확장 전략의 중요한 이정표를 기록한다.
More news about: HEC Cordyceps (Singapore)
Jun 14, 2026, 09:36 ET SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
CongoInterview Dr. Elliott Tenpenny, leading the Ebola response from the organization's international headquarters.Broadcast-quality b-roll and high-res photos
More news about: Samaritan's Purse
Jun 14, 2026, 08:45 ET Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively
More news about: Tradr ETFs
Jun 14, 2026, 03:15 ET Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
kinases tested in preclinical studies), non-covalent inhibitor of the enzyme BTK.1 BTK is a validated molecular target found across numerous B-cell leukemias and lymphomas including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL).2,3 Jaypirca is a U.S. FDA-approved
More news about: Eli Lilly and Company
Jun 14, 2026, 02:45 ET TAIWAN DESIGN POWER, 부산디자인페스티벌서 첫선…대만 디자인 혁신과 창의적 가치 선보여
키디스 파라다이스(Kiddie's Paradise Inc.), B&B 베스트 인더스트리얼(B&B Best Industrial Co., Ltd), 디 지아 인터내셔널(D. JIA International Ltd.),
More news about: Taiwan Design Research Institute; Industrial Development Administration, Ministry of Economic Affairs
Jun 13, 2026, 19:32 ET Babcock & Wilcox Deadline: BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
and/or failed to disclose that: (1) B&W's largest shareholder, BRC Group Holdings, Inc. ("BRC"), stood on both sides of the Power Generation Contract and had close ties to B&W's counterparty; (2) Applied Digital did not need the products and services that B&W would purportedly supply pursuant
More news about: THE ROSEN LAW FIRM, P. A.
Jun 13, 2026, 17:41 ET Employment & Labor Lawyers, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Victoria's Secret Stores, LLC, Alleging Failure to Provide Meal Periods and Rest Breaks
here.According to the lawsuit filed, Victoria's Secret Stores, LLC allegedly (a) failed to pay minimum wages, (b) failed to pay overtime wages, (c) failed to provide legally required
More news about: Blumenthal Nordrehaug Bhowmik De Blouw LLP
Jun 13, 2026, 16:06 ET Тематическая RGB-площадка Hisense представляет новую достопримечательность Чемпионата мира по футболу FIFA World Cup 2026™
участвовали в викторинах на футбольную тематику, по результатам которых для них создавались персонализированные постеры болельщиков с цветовым профилем R/G/B и выдавались индивидуальные рекомендации по продукции компании. По QR-кодам пользователей перенаправляли на американский веб-сайт Hisense для совершения
More news about: Hisense
Jun 13, 2026, 15:52 ET El evento temporal de Hisense inspirado en el RGB ilumina el nuevo punto de referencia de la Copa Mundial de la FIFA 2026™
participantes completaron cuestionarios sobre fútbol, lo que dio lugar a la creación de carteles con la identidad de los aficionados, con perfiles de color R/G/B, y a recomendaciones de productos a juego. Los códigos QR dirigieron a los usuarios a la página web de Hisense en EE. UU. para realizar compras. Los
More news about: Hisense